Completed PHASE4 INTERVENTIONAL 2-arm NCT04870021

Hepatitis B Birth Dose for Newborns (HepB-BirD)

Susceptibility to Hepatitis B in Neonates Given Birth Dose; Protocol for a Randomized Controlled Trial

Sponsor: Health Services Academy, Islamabad, Pakistan

Conditions Hepatitis B Immunization; Infection

Interventions Short text messages and calls to parents for compliance to routine immunization schedule recombinant hepatitis B vaccine ENGERIX 10 micrograms (µ gm),

Updated 4 times since 2021 Last updated: Apr 28, 2021 Started: Mar 15, 2015 Primary completion: Nov 30, 2015 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hepatitis B and Immunization; Infection, this trial is completed. The trial is conducted by Health Services Academy, Islamabad, Pakistan and has accumulated 4 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2021 — Jul 2024 [monthly]

Completed PHASE4

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Health Services Academy, Islamabad, Pakistan
Medical Research Council, Pakistan
Quaid-e-Azam University

Data source: Quaid-e-Azam University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hyderābād, Pakistan